Uncategorized Manhattan BioSolutions has been awarded REACH grant from the New York State Center For Biotechnology at the Stony Brook University by Mbio2018|Published June 1, 2018
Published January 3, 2024 Manhattan BioSolutions Enters into Evaluation and Potential Licensing Agreement with Biocytogen for Use of Innovative Antibodies in Targeted Therapies
Published May 15, 2023 Manhattan BioSolutions, Inc. Enters into License Option Agreement with Wisconsin Alumni Research Foundation (WARF) for the RNA Nuclease Technology
Published December 19, 2023 Manhattan BioSolutions Named as an Awardee of Science in the City QuickFire Challenge
Published February 16, 2024 Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates
